Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


OTCPK:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(27)
•••
Comment by montruson May 23, 2017 8:13am
309 Views
Post# 26271865

RE:RE:Pipestone Oil....aka CNOR..are drilling on BBI acreage

RE:RE:Pipestone Oil....aka CNOR..are drilling on BBI acreageAll good Mudpuddle.  We are all in this together and will see this through.  I picked up more warrants at .18c on Friday and will pick up even more from those who cannot stomach the ups and downs of a junior start-up.  I believe we will be 'well' rewarded in time.  GLTA
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities